59P Prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: Results from the French prospective FFCD cohort

Autor: Roth, G., Pellat, A., Piessen, G., Le Malicot, K., Schwarz, L., Gallois, C., Tougeron, D., Hautefeuille, V., Jary, M., Benoist, S., Ramee, J-F., Desgrippes, R., Muller, M., Manfredi, S., Bouche, O., Taieb, J.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S235-S236

507O Impact of lean body mass-based oxaliplatin dosage on neurotoxicity in adjuvant treatment of stage III colorectal cancer: Final results of the phase II randomized multicenter LEANOX trial

Autor: Assenat, E., Ben Abdelghani, M., Gourgou, S., Perrier, H., Akouz, F. Khemissa, Desgrippes, R., Galais, M.P., Janiszewski, C., Rinaldi, Y., Lepage, C., Tetreau, R., Senesse, P.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S431-S431

Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial

Autor: Aparicio, T., Bouché, O., Etienne, P. L., Barbier, E., Mineur, L., Desgrippes, R., Guerin-Meyer, V., Hocine, F., Martin, J., Le Brun-Ly, V., Cretin, J., Desramé, J., Rinaldi, Y., Cany, L., Falandry, C., Lefevre, L. B., Marous, M., Terrebonne, E., Mosser, L., Turpin, J., Turpin, A., Bauguion, L., Reichling, C., Eynde, M., Carola, E., Hiret, S.

Publikováno v: Digestive and Liver Disease, Vol. /, no./, p. / (2022)
Digestive and Liver Disease
Digestive and Liver Disease, 2022, pp.S1590-8658(22)00662-4. ⟨10.1016/j.dld.2022.08.036⟩

International audience; BACKGROUND: Colon adenocarcinoma mainly occurs in older patients. Oxaliplatin-based adjuvant chemotherapy improved disease-free survival after stage III colon cancer resection, but this improvement was not demonstrated in olde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e5a5ace431d56ccfe51565a387f0e2
https://pubmed.ncbi.nlm.nih.gov/36115817

1520P Perioperative treatment in resectable gastric cancer with spartalizumab combined with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): The GASPAR phase II trial

Autor: Dos Santos, M., Lequesne, J., Piessen, G., Desgrippes, R., Guimbaud, R., Pernot, S., Bouche, O., Hiret, S., Soularue, E., Dahan, L., Tougeron, D., Borg, C., Le Sourd, S.M., Samalin-Scalzi, E., Tellier-Castera, M., Leconte, A., Clarisse, B.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S856-S856

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.